Live Analyst Rating Changes 19795 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David S Macdonald
TRU

David S Macdonald

Truist Financial
Wall Street Analyst
★★★☆☆
#953
on 13Foresight · ranked by our own returns
54%
Success Rate
+2.9%
Average Return
45 of 83 calls profitable · +0.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 54% of David S Macdonald's ratings turned a profit when each position was held for 1 year — averaging +2.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

151 Buy 87 Hold 0 Sell
David's Stock Coverage 31 ratings · 2026-08-07
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
CVS
CVS Health
 Aug 06, 2026 BUY Strong Buy
+9.1% avg upside
39 analysts
$118.00
21.69% Upside
 +0.0% ·
ARDT
Ardent Health Partners, Inc.
 Aug 06, 2026 BUY Buy
+20.1% avg upside
16 analysts
$13.00
15.57% Upside
 · ·
PACS
PACS Group Inc
 Aug 06, 2026 BUY Strong Buy
+2.9% avg upside
9 analysts
$62.00
32.40% Upside
 +0.0% ·
PNTG
Pennant Group
 Aug 06, 2026 BUY Strong Buy
-10.2% avg upside
9 analysts
 — -0.1% ·
EHC
Encompass Health
 Aug 06, 2026 BUY Strong Buy
-9.7% avg upside
22 analysts
 — +0.0% ·
FMS
Fresenius Medical Care
 Aug 05, 2026 HOLD Hold
+70.0% avg upside
15 analysts
$25.00
3.75% Upside
 +0.0% ·
AHCO
AdaptHealth
 Aug 05, 2026 BUY Strong Buy
+93.5% avg upside
13 analysts
$9.00
49.43% Upside
 -12.4% ·
MD
Pediatrix Medical Group
 Aug 05, 2026 HOLD Buy
-16.4% avg upside
14 analysts
$28.00
5.27% Upside
 +0.0% ·
HCA
HCA Healthcare
 Aug 05, 2026 BUY Buy
-1.3% avg upside
36 analysts
$495.00
21.58% Upside
 +0.9% ·
DVA
DaVita
 Aug 05, 2026 HOLD Buy
-8.5% avg upside
17 analysts
 — · ·
LH
Labcorp Holdings
 Jul 31, 2026 BUY Strong Buy
-14.5% avg upside
37 analysts
$350.00
11.27% Upside
 +1.5% ·
CI
Cigna
 Jul 31, 2026 BUY Strong Buy
+26.8% avg upside
29 analysts
$350.00
27.51% Upside
 +0.5% ·
HUM
Humana
 Jul 30, 2026 HOLD Buy
+14.2% avg upside
34 analysts
$415.00
14.76% Upside
 -0.3% ·
ENSG
The Ensign Group
 Jul 30, 2026 HOLD Strong Buy
-7.6% avg upside
9 analysts
$207.00
14.38% Upside
 +2.3% ·
OPCH
Option Care Health
 Jul 30, 2026 BUY Strong Buy
+24.3% avg upside
20 analysts
$30.00
26.62% Upside
 +4.6% ·
CNC
Centene
 Jul 29, 2026 BUY Buy
+10.6% avg upside
29 analysts
$80.00
24.23% Upside
 +6.6% ·
THC
Tenet Healthcare
 Jul 28, 2026 BUY Strong Buy
-9.2% avg upside
27 analysts
$290.00
12.01% Upside
 -2.3% ·
DGX
Quest Diagnostics
 Jul 28, 2026 HOLD Buy
-22.9% avg upside
34 analysts
$250.00
5.48% Upside
 -0.0% ·
MOH
Molina Healthcare
 Jul 28, 2026 HOLD Buy
+23.2% avg upside
26 analysts
$225.00
17.08% Upside
 -2.9% ·
CYH
Community Health
 Jul 27, 2026 HOLD Sell
+40.7% avg upside
18 analysts
$3.25
10.16% Upside
 +2.6% ·
UNH
UnitedHealth
 Jul 17, 2026 BUY Strong Buy
+12.2% avg upside
36 analysts
$500.00
22.91% Upside
 -4.5% ·
ELV
Elevance Health
 Jul 16, 2026 BUY Strong Buy
+15.3% avg upside
33 analysts
$475.00
21.51% Upside
 +5.7% ·
AVAH
Aveanna Healthcare Holdings
 Jul 14, 2026 HOLD Buy
+0.7% avg upside
18 analysts
$11.00
17.96% Upside
 +0.2% ·
CON
Concentra Group Holdings Parent, Inc.
 Jul 14, 2026 BUY Strong Buy
+8.1% avg upside
11 analysts
$37.00
20.76% Upside
 -0.4% ·
GRDN
Guardian Pharmacy Services, Inc. Class A
 Jun 22, 2026 BUY Strong Buy
+4.0% avg upside
7 analysts
$47.00
19.19% Upside
 -5.6% ·
RDNT
Radnet
 May 19, 2026 BUY Strong Buy
+18.6% avg upside
10 analysts
$90.00
33.86% Upside
 +26.0% ·
SAIC
Science Applications
 Apr 03, 2023 HOLD Buy
-17.1% avg upside
20 analysts
$120.00
3.70% Downside
 +18.6% ·
PRVA
Privia Health Group
 Aug 12, 2022 BUY Strong Buy
+44.7% avg upside
26 analysts
$48.00
125.83% Upside
 -26.2% ·
AGL
Agilon Health
 Jul 14, 2022 BUY Buy
-32.2% avg upside
26 analysts
$33.00
64.49% Downside
 -35.7% ·
HCSG
Healthcare Services
 Oct 13, 2020 HOLD Buy
+9.6% avg upside
12 analysts
 — +1.5% ·
DE:FME
Fresenius Medical Care AG & Co. KGaA
 May 02, 2019 BUY Hold
+19.9% avg upside
23 analysts
$43.26
3.29% Upside
 -4.5% ·
🔒 26 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David S Macdonald — Frequently Asked Questions
How accurate are David S Macdonald's stock ratings?
Based on the calls 13Foresight could measure, about 54% of David's ratings were profitable over a one-year hold, with an average return of +3.4% per rating, or +0.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David S Macdonald is currently ranked #953 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on CVS, ARDT, PACS, PNTG, EHC, FMS, AHCO, MD, HCA, DVA, LH, CI and 19 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.